Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure.

Praveen Jha Ashish Kumar JhaVishwa Mohan DayalSanjeev Kumar JhaAmarendra Kumar

Published in: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology (2022)

Our study supports previous studies reporting that serum cystatin C is a better predictor for AKI development compared to serum creatinine. Cystatin C may be used as an early marker for new-onset AKI in hospitalized patients with ACLF.

Keyphrases

liver failure
acute kidney injury
hepatitis b virus
emergency department
uric acid
metabolic syndrome
adverse drug
drug induced